Event Brief
Mar 31, 2026 at 11:07 PM ET
Samsung Biologics acquires GSK's U.S. facility
By The BriefBrief
Samsung Biologics has completed the acquisition of GSK's U.S. facility for $280 million.
WHO: Samsung Biologics
WHAT: acquires GSK's U.S. facility
WHEN: Mar 31, 2026 at 10:46 PM ET
WHERE: USA
WHY: Reason not stated in article.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21436 of 21436
Same format. Every time.
Continue reading — sign in or create a free account with
